Skip to main content
TipRanks
Go Ultimate75% OFF

Chemring (CMN1) Q4 2025 Earnings Report

1 Followers

DE:CMN1 Q4 2025 EPS Results

Actual EPS
EUR 0.15
Consensus EPS
EUR 0.15
Beat/Miss
Beat by +EUR 0.00
One Year Ago EPS
EUR 0.15

DE:CMN1 Q4 2025 Revenue Results

Actual Revenue
EUR 315.51M
Expected Revenue
EUR 309.15M
Beat/Miss
Beat by +EUR 6.35M
YoY Revenue Growth
-8.29%

Earnings Announcement Details

Quarter
Q4 2025
Date
12/09/2025
Time
Before Open
Conference Call
Tuesday, December 9, 2025
DE:CMN1 Upcoming Earnings

Chemring's next earnings date is estimated for December 8, 2026, based on past reporting schedules.

Q4 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2025 Earnings Call Summary

Q4 2025
Earnings Call Date:Dec 09, 2025|% Change Since:15.07%|
Earnings Call Sentiment|Positive

The earnings call indicated strong performance and growth potential, particularly in the Energetics segment with a record order book and improved operational efficiency. However, challenges remain in the Sensors & Information segment due to delays in government spending and increased costs in Norway. The company is confident in its long-term growth strategy.

Company Guidance

During the call, Chemring reported a robust financial performance for the fiscal year ending October 31, 2025, despite short-term headwinds such as decreased U.K. government order placements. The company achieved a record order book of GBP 1.3 billion, up 32% year-on-year, with order intake rising 20% to GBP 781 million. Group revenue increased by 2% to GBP 498 million, and operating margin improved by 50 basis points to 14.8%. Earnings per share rose to 19.4p, and cash conversion was strong at 114%. The Countermeasures & Energetics segment saw a 17% revenue growth, with operating profit up 37% and margins increasing to 19.1%. Meanwhile, the Sensors & Information segment faced challenges, with revenue down 18% and operating profit falling 25%. Despite these challenges, operating margins were maintained at nearly 18%. The Board declared a final dividend of 5.3p, bringing the total dividend to 8p, up 3%. Looking ahead, Chemring is targeting significant growth in its Energetics and Sensors & Information segments, with strategic investments and acquisitions supporting its long-term revenue goal of GBP 1 billion by 2030.

  • Record Order Book and Strong Growth ProjectionsOrder intake reached GBP 781 million, up 20% year-on-year, delivering another record order book of GBP 1.3 billion, up 32% since last year. The company aims to double annual revenue to GBP 1 billion by 2030.
  • Energetics Segment SuccessEnergetics businesses achieved record order books, with revenue in the Countermeasures & Energetics segment growing by 17%. Operating profit increased by 37% and margin grew to 19.1%.
  • Improved Operational EfficiencyOperating margin improved from 14.3% to 14.8%, and cash conversion rose to 114%. EPS increased by 3% despite higher tax and finance costs.
  • Safety and ESG ProgressTotal recordable injury frequency rate fell to 0.48 from 0.69, demonstrating progress towards the zero harm ambition.

DE:CMN1 Earnings History

DE:CMN1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Dec 08, 20262026 (Q4)0.16-0.15――
Jun 02, 20262026 (Q2)0.070.070.08-10.29% (-0.01)
Dec 09, 20252025 (Q4)0.150.150.150.00% (+0.00)
Jun 03, 20252025 (Q2)0.080.080.083.03% (+0.00)
Dec 17, 20242024 (Q4)0.150.150.145.88% (+0.01)
Jun 04, 20242024 (Q2)0.120.080.08-1.49% (-0.00)
Dec 12, 20232023 (Q4)0.140.140.1126.60% (+0.03)
Jun 06, 20232023 (Q2)0.080.080.11-27.17% (-0.03)
Dec 13, 20222022 (Q4)0.090.110.111.90% (+0.01)
Jun 08, 20222022 (Q2)0.080.110.110.84% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed